Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Withdrawn1
Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06658080Recruiting

Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer

NCT05493059Unknown

Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study

NCT00514982Phase 2Withdrawn

Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

Showing all 3 trials

Research Network

Activity Timeline